Technical Analysis for CRMD - CorMedix Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Outside Day | Range Expansion | -1.15% | |
| Wide Bands | Range Expansion | -1.15% | |
| Oversold Stochastic | Weakness | -1.15% | |
| Slingshot Bearish | Bearish Swing Setup | -1.15% | |
| Morning Star | Bullish | -1.15% | |
| Wide Bands | Range Expansion | -1.15% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 9 hours ago |
| Down 1% | about 9 hours ago |
| Up 1% | about 9 hours ago |
| Down 2 % | 3 days ago |
| Down 1% | 3 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/06/2024
CorMedix Inc., a development stage pharmaceutical and medical device company, focuses on in-license, development, and commercialization of therapeutic products for the treatment of cardiac and renal dysfunction primarily in the dialysis and non-dialysis areas. It develops CRMD003 (Neutrolin), an antimicrobial/antifungal and anticoagulant combination in liquid formulation; and CRMD004, gel formulation of Neutrolin for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine CRM Catheter Dialysis Therapeutic Products Dysfunction Membrane Technology Stage Pharmaceutical Hemodialysis Kidney Nephrology Pharmaceutical And Medical Device Renal Dialysis Rockwell Medical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine CRM Catheter Dialysis Therapeutic Products Dysfunction Membrane Technology Stage Pharmaceutical Hemodialysis Kidney Nephrology Pharmaceutical And Medical Device Renal Dialysis Rockwell Medical
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 7.0 |
| 52 Week Low | 2.57 |
| Average Volume | 563,859 |
| 200-Day Moving Average | 3.99 |
| 50-Day Moving Average | 5.08 |
| 20-Day Moving Average | 4.70 |
| 10-Day Moving Average | 4.32 |
| Average True Range | 0.22 |
| RSI (14) | 32.43 |
| ADX | 29.76 |
| +DI | 15.62 |
| -DI | 27.85 |
| Chandelier Exit (Long, 3 ATRs) | 4.82 |
| Chandelier Exit (Short, 3 ATRs) | 4.71 |
| Upper Bollinger Bands | 5.52 |
| Lower Bollinger Band | 3.88 |
| Percent B (%b) | 0.24 |
| BandWidth | 34.99 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.22 |
| MACD Histogram | -0.0346 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.54 | ||||
| Resistance 3 (R3) | 4.55 | 4.47 | 4.49 | ||
| Resistance 2 (R2) | 4.47 | 4.41 | 4.47 | 4.48 | |
| Resistance 1 (R1) | 4.38 | 4.37 | 4.34 | 4.37 | 4.46 |
| Pivot Point | 4.30 | 4.30 | 4.29 | 4.30 | 4.30 |
| Support 1 (S1) | 4.21 | 4.24 | 4.17 | 4.20 | 4.10 |
| Support 2 (S2) | 4.13 | 4.20 | 4.13 | 4.08 | |
| Support 3 (S3) | 4.04 | 4.13 | 4.07 | ||
| Support 4 (S4) | 4.03 |
